guest ::
| Home > Publications Database > Monitoring of Inflammasome Activation of Macrophages and Microglia In Vitro, Part 2: Assessing Inflammasome Activation. > print |
| Home > Publications Database > Monitoring of Inflammasome Activation of Macrophages and Microglia In Vitro, Part 2: Assessing Inflammasome Activation. > print |
| 001 | 263610 | ||
| 005 | 20240402133626.0 | ||
| 020 | _ | _ | |a 978-1-0716-3436-3 (print) |
| 020 | _ | _ | |a 978-1-0716-3437-0 (electronic) |
| 024 | 7 | _ | |a 10.1007/978-1-0716-3437-0_29 |2 doi |
| 024 | 7 | _ | |a pmid:37639140 |2 pmid |
| 024 | 7 | _ | |a 1064-3745 |2 ISSN |
| 024 | 7 | _ | |a 1940-6029 |2 ISSN |
| 024 | 7 | _ | |a altmetric:153416888 |2 altmetric |
| 037 | _ | _ | |a DZNE-2023-00832 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 570 |
| 100 | 1 | _ | |a Lovotti, Marta |0 P:(DE-2719)9002115 |b 0 |u dzne |
| 245 | _ | _ | |a Monitoring of Inflammasome Activation of Macrophages and Microglia In Vitro, Part 2: Assessing Inflammasome Activation. |
| 260 | _ | _ | |a New York, NY |c 2024 |b Springer US |
| 295 | 1 | 0 | |a Tissue-Resident Macrophages / Mass, Elvira (Editor) ; New York, NY : Springer US, 2024, Chapter 29 ; ISSN: 1064-3745=1940-6029 ; ISBN: 978-1-0716-3436-3=978-1-0716-3437-0 ; doi:10.1007/978-1-0716-3437-0 |
| 300 | _ | _ | |a 431 - 451 |
| 336 | 7 | _ | |a BOOK_CHAPTER |2 ORCID |
| 336 | 7 | _ | |a Book Section |0 7 |2 EndNote |
| 336 | 7 | _ | |a bookPart |2 DRIVER |
| 336 | 7 | _ | |a INBOOK |2 BibTeX |
| 336 | 7 | _ | |a Output Types/Book chapter |2 DataCite |
| 336 | 7 | _ | |a Contribution to a book |b contb |m contb |0 PUB:(DE-HGF)7 |s 1694701678_30860 |2 PUB:(DE-HGF) |
| 490 | 0 | _ | |a Methods in Molecular Biology |v 2713 |
| 520 | _ | _ | |a Inflammasomes are macromolecular complexes that assemble upon the detection of cytoplasmic pathogen-associated or danger-associated signals and induce a necrotic type of cell death termed pyroptosis, facilitating pro-inflammatory cytokine release. Inflammasomes play a critical role in innate immunity and inflammatory response; however, they have also been associated with multiple diseases, including autoinflammatory and neurodegenerative conditions. In the following chapter, we describe methods to detect inflammasome activation and its downstream effects, including detection of ASC oligomerization, detection of activated caspase-1 and cleaved IL-1β, as well as read-outs for inflammasome-mediated cell death. |
| 536 | _ | _ | |a 351 - Brain Function (POF4-351) |0 G:(DE-HGF)POF4-351 |c POF4-351 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef Book Series, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a ASC speck |2 Other |
| 650 | _ | 7 | |a Cytokine production |2 Other |
| 650 | _ | 7 | |a Inflammasome |2 Other |
| 650 | _ | 7 | |a LDH release |2 Other |
| 650 | _ | 7 | |a Pyroptosis |2 Other |
| 650 | _ | 7 | |a Western blot |2 Other |
| 650 | _ | 7 | |a Inflammasomes |2 NLM Chemicals |
| 650 | _ | 7 | |a Caspase 1 |0 EC 3.4.22.36 |2 NLM Chemicals |
| 650 | _ | 2 | |a Microglia |2 MeSH |
| 650 | _ | 2 | |a Inflammasomes |2 MeSH |
| 650 | _ | 2 | |a Macrophages |2 MeSH |
| 650 | _ | 2 | |a Immunity, Innate |2 MeSH |
| 650 | _ | 2 | |a Caspase 1 |2 MeSH |
| 700 | 1 | _ | |a Mangan, Matthew |0 P:(DE-2719)2810930 |b 1 |u dzne |
| 700 | 1 | _ | |a McManus, Róisín M |0 P:(DE-2719)2811671 |b 2 |e First author |u dzne |
| 700 | 1 | _ | |a Shkarina, Kateryna |0 P:(DE-2719)9002209 |b 3 |e First author |u dzne |
| 700 | 1 | _ | |a Vasconcelos, Matilde B |b 4 |
| 700 | 1 | _ | |a Latz, Eicke |0 P:(DE-2719)2000062 |b 5 |e Last author |u dzne |
| 773 | _ | _ | |a 10.1007/978-1-0716-3437-0_29 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/263610/files/DZNE-2023-00832.pdf |
| 856 | 4 | _ | |u https://pub.dzne.de/record/263610/files/DZNE-2023-00832.pdf?subformat=pdfa |x pdfa |
| 909 | C | O | |o oai:pub.dzne.de:263610 |p VDB |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 0 |6 P:(DE-2719)9002115 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 1 |6 P:(DE-2719)2810930 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)2811671 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)9002209 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 5 |6 P:(DE-2719)2000062 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-351 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Brain Function |x 0 |
| 914 | 1 | _ | |y 2024 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-23 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-23 |
| 920 | 1 | _ | |0 I:(DE-2719)1013024 |k AG Latz |l Innate Immunity in Neurodegeneration |x 0 |
| 980 | _ | _ | |a contb |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1013024 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|